Pediatr Nephrol
Pediatric Nephrology (Berlin, Germany)
0931-041X
1432-198X
Springer-Verlag
Berlin/Heidelberg


1794138
17216262
357
10.1007/s00467-006-0357-2
Educational Feature


Pathophysiology of focal segmental glomerulosclerosis

Reidy
Kimberly

1

Kaskel
Frederick J.

fkaskel@aecom.yu.edu

2

1
Division of Pediatric Nephrology, Children’s Hospital at Montefiore, Bronx, NY 10467 USA 
2
Division of Pediatric Nephrology, Children’s Hospital at Montefiore, 111 East 210th St., Bronx, NY 10467 USA 

10
1
2007

3
2007

22
3
350
354
1
6
2006

1
8
2006

24
8
2006


© IPNA 2007

Focal segmental glomerulosclerosis (FSGS) is a major cause of idiopathic steroid-resistant nephrotic syndrome (SRNS) and end-stage kidney disease (ESKD). In recent years, animal models and studies of familial forms of nephrotic syndrome helped elucidate some mechanisms of podocyte injury and disease progression in FSGS. This article reviews some of the experimental and clinical data on the pathophysiology of FSGS.

Keywords
Focal segmental glomerulosclerosis (FSGS)
Nephrotic syndrome
Pathophysiology
Podocyte
Injury
Animal models
Nephrin
Podocin
Transforming growth factor (TGFβ)
Tubulointerstitial

issue-copyright-statement
© IPNA 2007




Learning objectives
Discuss the experimental and clinical data on the pathophysiology of FSGS

Review the alterations in glomerular structure and function associated with FSGS

To identify potential mechanisms responsible for disease progression in FSGS

Distinguish some targets for the future therapy of FSGS



1
2
3
2
1
4
]; this review focuses on the pathophysiology of primary FSGS (i.e., with no underlying illness).
5
1
6
2
7
1
6
Fig. 1
A
B
9
]




1
1
1
7
8
].
7
9
10
].
5
6
6
9
6
9
7
7
7
9
].
10
6
9
11
NEPH-1
6
10
].
9
10
].
6
10
9
10
12
10
13
14
10
]. The role of the other components of the slit diaphragm in the pathophysiology of FSGS is not yet clear.
10
15
17
18
].
19
20
20
20
].
21
22
23
23
].
1
5
].
2
8
24
7
24
24
24
25
Fig. 2
Factors involved in the progression of FSGS to end-stage kidney disease (ESKD): initial loss or injury to podocytes (related to defects in membrane proteins or cytoskeleton instability) leads to cytokine release, mechanical stress, hyperfiltration, and glomerular hypertrophy. These factors lead to upregulation of an inflammatory response mediated by monocytes, macrophages, and T-cells. The end result is collagen matrix deposition and fibrosis, and progression to ESKD




9
26
9
].
1
27
28
9
29
].
24
24
24
].
24
24
9
29
].
30
], these pathways of podocyte injury and disease progression provide important targets for future intervention. Trials have already been initiated to antagonize cytokines, such as TGFβ. Future therapeutic targets may include factors involved in podocyte protection or tubulointerstitial injury.
Questions
FSGS may result from immune-complex-mediated damage to endothelial cells

Alterations in components of the slit diaphragm may play a role in the pathogenesis of FSGS

Proliferation of podocytes leads to cytokine release and mechanical stress, resulting in scarring and sclerosis of the glomeruli

Mutations in a chloride channel have been associated with FSGS and may be pathogenic




Sodium channel mutation

Alpha-actinin-4

Nephrin

Podocin




Downregulation of transforming growth factor β (TGFβ)

Decreased glomerular filtration

Tubulointerstitial injury

Blockade of the renin-angiotensin system




Has no effect on clinical course

May be decreased by treatment with angiotensin-converting enzyme (ACE) inhibitors

Results from an increased number of glomerular foot processes

Leads to the loss of mesangial matrix




A circulating factor may play a role in the pathogenesis of FSGS

Proliferation of parietal epithelial cells has been identified in collapsing FSGS

Podocyte loss due to necrosis appears to play a role in the pathogenesis of FSGS

CD2-associated protein, FAT, nephrin, and podocin are examples of slit diaphragm proteins







References
1.
D’Agati
VD


Pathologic classification of focal segmental glomerulosclerosis
Semin Nephrol
2003
23
2
117
134
10.1053/snep.2003.50012

12704572


2.
Schnaper
HW


Idiopathic focal segmental glomerulosclerosis
Semin Nephrol
2003
23
2
183
193
10.1053/snep.2003.50016

12704578


3.
Dingli
D

Larson
DR

Plevak
MF

Grande
JP

Kyle
RA


Focal and segmental glomerulosclerosis and plasma cell proliferative disorders
Am J Kidney Dis
2005
46
2
278
282
10.1053/j.ajkd.2005.05.004

16112046


4.
Kambham
N

Markowitz
GS

Valeri
AM

Lin
J

D’Agati
VD


Obesity-related glomerulopathy: an emerging epidemic
Kidney Int
2001
59
4
1498
1509
10.1046/j.1523-1755.2001.0590041498.x

11260414


5.
Kriz
W


The pathogenesis of “classic” focal segmental glomerulosclerosis—lessons from rat models
Nephrol Dial Transplant
2003
18
Suppl 6
vi39
vi44

12953041


6.
Asanuma
K

Mundel
P


The role of podocytes in glomerular pathobiology
Clin Exp Nephrol
2003
7
4
255
259
10.1007/s10157-003-0259-6

14712353


7.
Fogo
AB


Animal models of FSGS: lessons for pathogenesis and treatment
Semin Nephrol
2003
23
2
161
171
10.1053/snep.2003.50015

12704576


8.
Meyrier
A


E pluribus unum: the riddle of focal segmental glomerulosclerosis
Semin Nephrol
2003
23
2
135
140
10.1053/snep.2003.50013

12704573


9.
Kwoh
C

Shannon
MB

Miner
JH

Shaw
A


Pathogenesis of nonimmune glomerulopathies
Annu Rev Pathol Mech Dis
2006
1
349
374
10.1146/annurev.pathol.1.110304.100119

Kwoh C, Shannon MB, Miner JH, Shaw A (2006) Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol Mech Dis 1:349–374 

10.
Tryggvason
K

Patrakka
J

Wartiovaara
J


Hereditary proteinuria syndromes and mechanisms of proteinuria
N Engl J Med
2006
354
13
1387
1401
10.1056/NEJMra052131

16571882


11.
Kestila
M

Lenkkeri
U

Mannikko
M

Lamerdin
J

McCready
P

Putaala
H

Ruotsalainen
V

Morita
T

Nissinen
M

Herva
R

Kashtan
C

Peltonen
L

Holmberg
C

Olsen
A

Tryggvason
K


Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome
Mol Cell
1998
1
4
575
582
10.1016/S1097-2765(00)80057-X

9660941


12.
Karle
SM

Uetz
B

Ronner
V

Glaeser
L

Hildebrandt
F

Fuchshuber
A


Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome
J Am Soc Nephrol
2002
13
2
388
393

11805166


13.
Shih
NY

Li
J

Karpitskii
V

Nguyen
A

Dustin
ML

Kanagawa
O

Miner
JH

Shaw
AS


Congenital nephrotic syndrome in mice lacking CD2-associated protein
Science
1999
286
5438
312
315
10.1126/science.286.5438.312

10514378


14.
Kim
JM

Wu
H

Green
G

Winkler
CA

Kopp
JB

Miner
JH

Unanue
ER

Shaw
AS


CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility
Science
2003
300
5623
1298
1300
10.1126/science.1081068

12764198


15.
Ghiggeri
GM

Artero
M

Carraro
M

Perfumo
F


Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor
Nephrol Dial Transplant
2001
16
5
882
885
10.1093/ndt/16.5.882

11328888


16.
Kaplan
JM

Kim
SH

North
KN

Rennke
H

Correia
LA

Tong
HQ

Mathis
BJ

Rodriguez-Perez
JC

Allen
PG

Beggs
AH

Pollak
MR


Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis
Nat Genet
2000
24
3
251
256
10.1038/73456

10700177


17.
Yao
J

Le
TC

Kos
CH

Henderson
JM

Allen
PG

Denker
BM

Pollak
MR


Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein
PLoS Biol
2004
2
6
787
794
10.1371/journal.pbio.0020167

Yao J, Le TC, Kos CH, Henderson JM, Allen PG, Denker BM, Pollak MR (2004) Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol 2(6):787–794 

18.
Winn
MP

Conlon
PJ

Lynn
KL

Farrington
MK

Creazzo
T

Hawkins
AF

Daskalakis
N

Kwan
SY

Ebersviller
S

Burchette
JL

Pericak-Vance
MA

Howell
DN

Vance
JM

Rosenberg
PB


A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis
Science
2005
17
5729
1801
1804
10.1126/science.1106215

15879175


19.
Savin
VJ

McCarthy
ET

Sharma
M


Permeability factors in focal segmental glomerulosclerosis
Semin Nephrol
2003
23
2
147
160
10.1053/snep.2003.50024

12704575


20.
Daskalakis
N

Winn
MP


Focal and segmental glomerulosclerosis: varying biologic mechanisms underlie a final histopathologic end point
Semin Nephrol
2006
26
2
89
94
10.1016/j.semnephrol.2005.09.001

16530601


21.
Barisoni
L

Kriz
W

Mundel
P

D’Agati
V


The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
J Am Soc Nephrol
1999
10
1
51
61
10.1159/000017097

9890309


22.
Schwimmer
JA

Markowitz
GS

Valeri
A

Appel
GB


Collapsing glomerulopathy
Semin Nephrol
2003
23
2
209
218
10.1053/snep.2003.50019

12704581


23.
Dijkman
H

Smeets
B

Laak
J

Steenbergen
E

Wetzels
J


The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis
Kidney Int
2005
68
4
1562
1572
10.1111/j.1523-1755.2005.00568.x

16164633


24.
Harris
RC

Neilson
EG


Toward a unified theory of renal progression
Annu Rev Med
2006
57
365
380
10.1146/annurev.med.57.121304.131342

16409155


25.
Kang
DH

Joly
AH

Oh
S-W

Hugo
C

Kerjaschki
D

Gordon
KL

Mazzali
M

Jefferson
JA

Hughes
J

Madsen
KM

Schreiner
GF

Johnson
RJ


Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1
J Am Soc Nephrol
2001
12
7
1434
1447

11423572


26.
Hostetter
TH


Hyperfiltration and glomerulosclerosis
Semin Nephrol
2003
23
2
194
199
10.1053/anep.2003.50017

12704579


27.
Rodriguez-Iturbe
B

Johnson
RJ

Herrera-Acosta
J


Tubulointerstitial damage and progression of renal failure
Kidney Int
2005
68
Supp 99
S82
S86
10.1111/j.1523-1755.2005.09915.x

Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J (2005) Tubulointerstitial damage and progression of renal failure. Kidney Int 68(Supp 99):S82–S86 

28.
Walls
J


Relationship between proteinuria and progressive renal disease
Am J Kidney Dis
2001
37
1 Supp 2
S13
S16

11158854


29.
Korbet
SM


Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis
Semin Nephrol
2003
23
2
219
228
10.1053/snep.2003.50020

12704582


30.
Filler
G

Young
E

Geier
P

Carpenter
B

Drukker
A

Feber
J


Is there really an increase in non-minimal change nephrotic syndrome in children?
Am J Kidney Dis
2003
42
6
1107
1113
10.1053/j.ajkd.2003.08.010

14655180



KR is a Pediatric Nephrology Trainee supported by grant no. NIH T32 DK007110 30. FJK is supported in part by NIH DK63549-04.

Answers
B

A

C

B

C







